Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: Construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 4, 2010, Pages 452-461

  Fincham, Dylan ^a   Kagee, Ashraf ^a   Swartz, Leslie ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

HIV vaccine trial; Inhibitors and Facilitators of Willingness to Participate Scale (WPS); South Africa

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CRONBACH ALPHA COEFFICIENT; DRUG RESEARCH; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INHIBITORS ANF FACILTATORS OF WILLINGNESS TO PARTICIPATE SCALE; INTERNAL CONSISTENCY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PSYCHOMETRY; SOCIAL ASPECT; SOUTH AFRICA; TRUST;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AIDS VACCINES; CHOICE BEHAVIOR; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PATIENT PARTICIPATION; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA; YOUNG ADULT;

EID: 77951682570     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903202939     Document Type: Article

References (36)

1. Allen, M.A., Israel, H., Rybczyck, K., Pugliese, M.A., Loughran, K., Wagner, L., et al. (2001). Trial-related discrimination in HIV vaccine clinical trials. AIDS Research and Human Retroviruses, 17(8), 667-674.
2. Bartholow, B.N., MacQueen, K.M., Douglas, J.M., Buchbinder, S., McKirnan, D., & Judson, F.N. (1997). Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 16(2), 108-115.
3. Boily, M.C., Masse, B.R., Desai, K., Alary, M., & Anderson, R.M. (1999). Some important issues in the planning of phase III HIV vaccine efficacy trials. Vaccine, 17, 989-1004.
4. Braunstein, J.B., Sherber, N.S., Schulman, S.P., Ding, E.L., & Powe, N.R. (2008). Race, medical researcher distrust, perceived harm and willingness to participate in cardiovascular prevention trials. Medicine, 87(1), 1-9.
5. Buchbinder, S.P., Metch, B., Holte, S.E., Scheer, S., Coletti, A., & Vittinghof, E. (2004). Determinants of enrolment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndromes, 36(1), 604-612.
6. Celentano, D.D., Beyrer, C., Natpratan, C., Eiumtrakul, S., Sussman, L., Renzullo, P.O., et al. (1995). Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS, 9(9), 1079-1083.
7. DerSimonian, R., Charette, L.J., McPeek, B., & Mosteller, F. (1982). Reporting on methods in clinical trials. New England Journal of Medicine, 306, 1332-1337.
8. Golub, E.T., Purvis, L.A., Sapun, M., Safaeian, M., Beyrer, C, Vlahov, D., et al. (2005). Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS and Behavior, 9(3), 301-309.
9. Halpern, S.D., Karlawish, J.H., & Berlin, J.A. (2002). The continuing unethical conduct of underpowered clinical trials. The Journal of the American Medical Association, 288(3), 358-362.
10. Hays, R.B., & Kegeles, S.M. (1999). Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(2), 164-171.
11. Hennessy, M., MacQueen, K., McKirnan, D.J., Buchbinder, S., Judson, F., Douglas, J.M., et al. (1996). A factorial survey study to assess the acceptability of HIV vaccine trial designs. Controlled Clinical Trials, 17, 209-220.
12. Jenkins, R.A., Torugsa, K., Markowitz, L.E., Mason, C.J., Jamroentana, V., Brown, A.E., et al. (2000). Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections, 76, 386-392.
13. The Joint United Nations Program on HIV/AIDS (2007, December). Report on the global AIDS epidemic. Retrieved March 18, 2008, from http://www.avert.org/ worldstats.htm
14. Kerns, T.A. (1997). Ethical issues in HIV vaccine trials. New York: St. Martins Press.
15. Koblin, B.A., Holte, S., Lenderking, B., & Heagerty, P. (2000). Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. Journal of Acquired Immune Deficiency Syndromes, 24(5), 451-457.
16. Leach, M., & Fairhead, J. (2007). Vaccine anxieties: Global science, child health and society. London: Earthscan.
17. Lesch, A., Kafaar, Z., Kagee, A., & Swartz, L. (2006). Community members' perceptions of facilitators and inhibitors to participation in HIV vaccine trials. South African Journal of Psychology, 36(4), 74-101.
18. Lindegger, G., & Richter, L.M. (2000). HIV vaccine trials: Critical issues in informed consent. South African Journal of Science, 96, 313-317.
19. MacQueen, K.M., Vanichseni, S., Kitayaporn, D.S., Lin, L., Buavirat, A., Naiwatanakul, T., et al. (1999). Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes, 21(3), 243-251.
20. McCluskey, M.M., Alexander, S.B., Larkin, B.D., Mur-guia, M., & Wakefield, S. (2005). An HIV vaccine: As we build it, will they come? Health Affairs, 24(3), 643-651.
21. McGrath, J.W., George, K., Svilar, G., Ihler, E., Mafigiri, D., Kabugo, M., et al. (2001). Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. Journal of Acquired Immune Deficiency Syndromes, 27(4), 381-388.
22. Mills, E., Cooper, C., Guyatt, G., Gilchrist, A., Rachlis, B., Sulway, C., et al. (2004). Barriers to participating in an HIV vaccine trial: A systematic review. AIDS, 18(17), 2235-2242.
23. Moodley, K., Barnes, J., van Rensburg, E.J., & Myer, L. (2002). Willingness to participate in South African HIV vaccine trials: Concerns of medical professionals in the Western Cape. South African Medical Journal, 92(11), 904-906.
24. Newman, P.A., Duan, N., Lee, S.J., Rudy, E., Seiden, D., Kakinami, L., et al. (2007). Willingness to participate in HIV vaccine trials: The impact of trial attributes. Preventive Medicine, 44, 554-557.
25. Nyamathi, A., Koniak-Griffin, D., Tallen, L., Gonzalez-Figueroa, E., Levson, L., Mosley, Y., et al. (2004). Use of community-based participatory research in preparing low income and homeless minority populations for future HIV vaccines. Journal of Interprofessional Care, 18(4), 369-380. (Pubitemid 40100609)
26. O'Connell, J.M., Hogg, R.S., Chan, K., Strathdee, S.A., McLean, N., Martindale, S.L., et al. (2002). Willingness to participate and enroll in a phase III preventative HIV-1 vaccine trial. Journal of Acquired Immune Deficiency Syndromes, 31, 521-528. (Pubitemid 35448660)
27. Rudy, E.T., Newman, P.A., Duan, N., Kelly, E.M., Roberts, J., & Seiden, D.S. (2005). HIV vaccine acceptability among women at risk: Perceived barriers and facilitators to future HIV vaccine uptake. AIDS Education and Prevention, 17(3), 253-267. (Pubitemid 40840057)
28. Sahay, S., Mehendale, S., Sane, S., Brahme, R., Brown, A., Charron, K., et al. (2005). Correlates of HIV vaccine trial participation: An Indian perspective. Vaccine, 23, 1315-1358. (Pubitemid 40127327)
29. Sengupta, S., Strauss, R.P., DeVellis, R., Quinn, S.C., DeVellis, B., & Ware, W.B. (2000). Factors affecting African-American participation in AIDS research. Journal of Acquired Immune Deficiency Syndromes, 24, 275-284.
30. Sheon, A.R., Wagner, L., McElrath, M.J., Keefer, M.C., & Zimmerman, E. (1998). Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirol-ogy, 19, 519-526. (Pubitemid 128704084)
31. Shisana, O., Rehle, T., Simbayi, L.C., Parker, W., Zuma, K., Bhana, A., et al. (2005). South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey. Cape Town: HSRC Press.
32. Slack, C, Lindegger, G., Vardas, E., Richter, L., Strode, A., & Wassenaar, D. (2000). Ethical issues in HIV vaccine trials in South Africa. South African Journal of Science, 96, 291-295.
33. Slack, C., Stobie, M., Milford, C., Lindegger, G., Wassenaar, D., Strode, A., et al. (2005). Provision of HIV treatment in HIV preventative vaccine trials: A developing country perspective. Social Science and Medicine, 60, 1197-1208. (Pubitemid 40038752)
34. Smit, J., Middelkoop, K., Myer, L., Lindegger, G., Swartz, L., Seedat, S., et al. (2005). Sociobehavioural challenges to phase III HIV vaccine trials in sub Saharan Africa. African Health Sciences, 5(3), 198-206. (Pubitemid 44237260)
35. Strauss, R.P., Sengupta, S., Kegeles, S., McLellan, E., Metzger, D., Eyre, S., et al. (2001). Willingness to volunteer in future preventative HIV vaccine trials: Issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes, 26(1), 63-71. (Pubitemid 32117677)
36. Swartz, L., Kagee, A., Lesch, A., Kafaar, Z., Fincham, D.S., & Ntlemeza, B. (2006). Community members' perceptions of facilitators and inhibitors to participation in HIV/AIDS vaccine trials. Stellenbosch: Sociobehavioural Group, South African AIDS Vaccine Initiative.